Peng Yin

Peng Yin serves as Chairman and CEO of Accucise Diagnostics Inc. and Senior Vice President and CTO of Sansure Biotech Inc. With extensive experience in the field, Peng holds a position as an Executive Committee Member in the Emerging Technology Division of the International Federation of Clinical Chemistry and Laboratory Medicine and is a Fellow of the American Association for Clinical Chemistry. Peng has contributed to various editorial boards, including the Journal of Virology & Current Research and the Journal of Human Virology & Retro Virology. Previous roles include Co-Chief Executive Officer at Biotime and Head of ADD Asia R&D at Abbott, where leadership encompassed establishing and managing R&D centers in China and Japan. Educational achievements include a Master of Business Administration from Lake Forest Graduate School of Management and a PhD in Molecular Virology from the University of Manitoba, complemented by postdoctoral studies at Harvard Medical School.